Gojković, et al.. Analysis of Survival at Metastatic Melanoma Patients Treated with Vemurafenib - a Three Year Single Institution Study. Centre for Evaluation in Education and Science (CEON/CEES), Dec. 2018, doi:10.7251/scmed1802126g.